Early versus delayed treatment of primary epistaxis in the United States
JA Villwock, P Goyal - International Forum of Allergy & …, 2014 - Wiley Online Library
Background Epistaxis treatment is variable. This study sought to determine demographic,
management, and outcome differences in patients treated with early (< 24 hours) vs late …
management, and outcome differences in patients treated with early (< 24 hours) vs late …
Early versus delayed treatment of primary epistaxis in the United States.
JA Villwock, P Goyal - International Forum of Allergy & …, 2014 - search.ebscohost.com
Background Epistaxis treatment is variable. This study sought to determine demographic,
management, and outcome differences in patients treated with early (< 24 hours) vs late …
management, and outcome differences in patients treated with early (< 24 hours) vs late …
Early versus delayed treatment of primary epistaxis in the United States
JA Villwock, P Goyal - International forum of allergy & …, 2014 - pubmed.ncbi.nlm.nih.gov
Background Epistaxis treatment is variable. This study sought to determine demographic,
management, and outcome differences in patients treated with early (< 24 hours) vs late …
management, and outcome differences in patients treated with early (< 24 hours) vs late …
Early versus delayed treatment of primary epistaxis in the United States.
JA Villwock, P Goyal - International Forum of Allergy & Rhinology, 2013 - europepmc.org
Background Epistaxis treatment is variable. This study sought to determine demographic,
management, and outcome differences in patients treated with early (< 24 hours) vs late …
management, and outcome differences in patients treated with early (< 24 hours) vs late …